MTOR and metastatic melanoma: The expression of components of the renin–angiotensin system by phenotypic CSCs in metastatic melanoma, coupled with the interactions between the renin–angiotensin system and the overactive Ras/RAF/MAPK/ERK and PI3K/AKT/mTOR pathways, present vast therapeutic possibilities.